Lack of Neuronal IFN-β-IFNAR Causes Lewy Body- and Parkinson's Disease-like Dementia

Cell

Volumn 163, Issue 2, 2015, Pages 324-339

  Ejlerskov, Patrick ^a   Hultberg, Jeanette Göransdotter ^a   Wang, JunYang ^a   Carlsson, Robert ^a   Ambjørn, Malene ^a   Kuss, Martin ^a   Liu, Yawei ^a   Porcu, Giovanna ^a   Kolkova, Kateryna ^a   Friis Rundsten, Carsten ^a   Ruscher, Karsten ^b   Pakkenberg, Bente ^c   Goldmann, Tobias ^d   Loreth, Desiree ^d   Prinz, Marco ^d   Rubinsztein, David C ^e   Issazadeh Navikas, Shohreh ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b LUND UNIVERSITY   (Sweden)

^c BISPEBJERG HOSPITAL   (Denmark)

^d UNIVERSITY OF FREIBURG   (Germany)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON RECEPTOR; ALPHA SYNUCLEIN; BETA INTERFERON; BETA INTERFERON RECEPTOR; ALPHA BETA INTERFERON RECEPTOR; IFNAR1 PROTEIN, MOUSE; TRANSCRIPTOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPHAGY; CONTROLLED STUDY; DEMENTIA; DOPAMINERGIC NERVE CELL; LEWY BODY; MITOCHONDRION; MOUSE; NERVE DEGENERATION; NERVE FIBER GROWTH; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; DIFFUSE LEWY BODY DISEASE; DISEASE MODEL; GENE THERAPY; GENETICS; METABOLISM; NERVE CELL; PATHOLOGY;

ALPHA-SYNUCLEIN; ANIMALS; AUTOPHAGY; DISEASE MODELS, ANIMAL; GENETIC THERAPY; INTERFERON-BETA; LEWY BODY DISEASE; MICE; MICE, INBRED C57BL; NEURONS; PARKINSON DISEASE; RECEPTOR, INTERFERON ALPHA-BETA; SIGNAL TRANSDUCTION; TRANSCRIPTOME;

EID: 84943638074     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2015.08.069     Document Type: Article

References (46)

1. K. Arima, S. Hirai, N. Sunohara, K. Aoto, Y. Izumiyama, K. Uéda, K. Ikeda, and M. Kawai Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies Brain Res. 843 1999 53 61
2. B. Artegiani, A.M. de Jesus Domingues, S. Bragado Alonso, E. Brandl, S. Massalini, A. Dahl, and F. Calegari Tox: a multifunctional transcription factor and novel regulator of mammalian corticogenesis EMBO J. 34 2015 896 910
3. T. Bartels, J.G. Choi, and D.J. Selkoe α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation Nature 477 2011 107 110
4. K. Baruch, A. Deczkowska, E. David, J.M. Castellano, O. Miller, A. Kertser, T. Berkutzki, Z. Barnett-Itzhaki, D. Bezalel, T. Wyss-Coray, and et al. Aging. Aging-induced type I interferon response at the choroid plexus negatively affects brain function Science 346 2014 89 93
5. V. Brochard, B. Combadière, A. Prigent, Y. Laouar, A. Perrin, V. Beray-Berthat, O. Bonduelle, D. Alvarez-Fischer, J. Callebert, J.M. Launay, and et al. Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease J. Clin. Invest. 119 2009 182 192
6. R.K. Chaturvedi, and M. Flint Beal Mitochondrial diseases of the brain Free Radic. Biol. Med. 63 2013 1 29
7. A. Chort, S. Alves, M. Marinello, B. Dufresnois, J.G. Dornbierer, C. Tesson, M. Latouche, D.P. Baker, M. Barkats, K.H. El Hachimi, and et al. Interferon β induces clearance of mutant ataxin 7 and improves locomotion in SCA7 knock-in mice Brain 136 2013 1732 1745
8. E.E. Congdon, J. Gu, H.B. Sait, and E.M. Sigurdsson Antibody uptake into neurons occurs primarily via clathrin-dependent Fcγ receptor endocytosis and is a prerequisite for acute tau protein clearance J. Biol. Chem. 288 2013 35452 35465
9. S.W. Davies, M. Turmaine, B.A. Cozens, M. DiFiglia, A.H. Sharp, C.A. Ross, E. Scherzinger, E.E. Wanker, L. Mangiarini, and G.P. Bates Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation Cell 90 1997 537 548
10. M. Decressac, B. Mattsson, P. Weikop, M. Lundblad, J. Jakobsson, and A. Björklund TFEB-mediated autophagy rescues midbrain dopamine neurons from α-synuclein toxicity Proc. Natl. Acad. Sci. USA 110 2013 E1817 E1826
11. P. Ejlerskov, I. Rasmussen, T.T. Nielsen, A.L. Bergström, Y. Tohyama, P.H. Jensen, and F. Vilhardt Tubulin polymerization-promoting protein (TPPP/p25α) promotes unconventional secretion of α-synuclein through exophagy by impairing autophagosome-lysosome fusion J. Biol. Chem. 288 2013 17313 17335
12. L. Erlandsson, R. Blumenthal, M.L. Eloranta, H. Engel, G. Alm, S. Weiss, and T. Leanderson Interferon-beta is required for interferon-alpha production in mouse fibroblasts Curr. Biol. 8 1998 223 226
13. E. Fossale, I.S. Seong, K.R. Coser, T. Shioda, I.S. Kohane, V.C. Wheeler, J.F. Gusella, M.E. MacDonald, and J.M. Lee Differential effects of the Huntington's disease CAG mutation in striatum and cerebellum are quantitative not qualitative Hum. Mol. Genet. 20 2011 4258 4267
14. P.T. Francis Biochemical and pathological correlates of cognitive and behavioural change in DLB/PDD J. Neurol. 256 Suppl 3 2009 280 285
15. M. Goedert, M.G. Spillantini, K. Del Tredici, and H. Braak 100 years of Lewy pathology Nat. Rev. Neurol. 9 2013 13 24
16. M.G. Gutierrez, D.B. Munafó, W. Berón, and M.I. Colombo Rab7 is required for the normal progression of the autophagic pathway in mammalian cells J. Cell Sci. 117 2004 2687 2697
17. T. Hara, K. Nakamura, M. Matsui, A. Yamamoto, Y. Nakahara, R. Suzuki-Migishima, M. Yokoyama, K. Mishima, I. Saito, H. Okano, and N. Mizushima Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice Nature 441 2006 885 889
18. H. Harris, and D.C. Rubinsztein Control of autophagy as a therapy for neurodegenerative disease Nat. Rev. Neurol. 8 2012 108 117
19. J.M. Hyttinen, M. Niittykoski, A. Salminen, and K. Kaarniranta Maturation of autophagosomes and endosomes: a key role for Rab7 Biochim. Biophys. Acta 1833 2013 503 510
20. K.A. Jellinger Morphological substrates of mental dysfunction in Lewy body disease: an update J. Neural Transm. Suppl. 59 2000 185 212
21. K.A. Jellinger Neuropathological aspects of Alzheimer disease, Parkinson disease and frontotemporal dementia Neurodegener. Dis. 5 2008 118 121
22. K.A. Jellinger, and J. Attems Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease Acta Neuropathol. 115 2008 427 436
23. M. Komatsu, S. Waguri, T. Chiba, S. Murata, J. Iwata, I. Tanida, T. Ueno, M. Koike, Y. Uchiyama, E. Kominami, and K. Tanaka Loss of autophagy in the central nervous system causes neurodegeneration in mice Nature 441 2006 880 884
24. Y.K. Lee, D.H. Kwak, K.W. Oh, S.Y. Nam, B.J. Lee, Y.W. Yun, Y.B. Kim, S.B. Han, and J.T. Hong CCR5 deficiency induces astrocyte activation, Abeta deposit and impaired memory function Neurobiol. Learn. Mem. 92 2009 356 363
25. B. Linnartz, J. Kopatz, A.J. Tenner, and H. Neumann Sialic acid on the neuronal glycocalyx prevents complement C1 binding and complement receptor-3-mediated removal by microglia J. Neurosci. 32 2012 946 952
26. C.F. Lippa, H. Fujiwara, D.M. Mann, B. Giasson, M. Baba, M.L. Schmidt, L.E. Nee, B. O'Connell, D.A. Pollen, P. St George-Hyslop, and et al. Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes Am. J. Pathol. 153 1998 1365 1370
27. Y. Liu, I. Teige, B. Birnir, and S. Issazadeh-Navikas Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE Nat. Med. 12 2006 518 525
28. Y. Liu, R. Carlsson, M. Ambjørn, M. Hasan, W. Badn, A. Darabi, P. Siesjö, and S. Issazadeh-Navikas PD-L1 expression by neurons nearby tumors indicates better prognosis in glioblastoma patients J. Neurosci. 33 2013 14231 14245
29. Y. Liu, R. Carlsson, M. Comabella, J. Wang, M. Kosicki, B. Carrion, M. Hasan, X. Wu, X. Montalban, M.H. Dziegiel, and et al. FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS Nat. Med. 20 2014 272 282
30. R.B. Maccioni, L.E. Rojo, J.A. Fernández, and R.O. Kuljis The role of neuroimmunomodulation in Alzheimer's disease Ann. N Y Acad. Sci. 1153 2009 240 246
31. F. Mori, Y.S. Piao, S. Hayashi, H. Fujiwara, M. Hasegawa, M. Yoshimoto, T. Iwatsubo, H. Takahashi, and K. Wakabayashi Alpha-synuclein accumulates in Purkinje cells in Lewy body disease but not in multiple system atrophy J. Neuropathol. Exp. Neurol. 62 2003 812 819
32. R.E. Mrak, and W.S. Griffin Dementia with Lewy bodies: Definition, diagnosis, and pathogenic relationship to Alzheimer's disease Neuropsychiatr. Dis. Treat. 3 2007 619 625
33. N.S. Narayanan, R.L. Rodnitzky, and E.Y. Uc Prefrontal dopamine signaling and cognitive symptoms of Parkinson's disease Rev. Neurosci. 24 2013 267 278
34. A.L. Nelson Antibody fragments: hope and hype MAbs 2 2010 77 83
35. M. Prinz, H. Schmidt, A. Mildner, K.P. Knobeloch, U.K. Hanisch, J. Raasch, D. Merkler, C. Detje, I. Gutcher, J. Mages, and et al. Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system Immunity 28 2008 675 686
36. E. Rockenstein, S. Nuber, C.R. Overk, K. Ubhi, M. Mante, C. Patrick, A. Adame, M. Trejo-Morales, J. Gerez, P. Picotti, and et al. Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo Brain 137 2014 1496 1513
37. J. Segura-Aguilar, I. Paris, P. Muñoz, E. Ferrari, L. Zecca, and F.A. Zucca Protective and toxic roles of dopamine in Parkinson's disease J. Neurochem. 129 2014 898 915
38. K.C. Sheehan, K.S. Lai, G.P. Dunn, A.T. Bruce, M.S. Diamond, J.D. Heutel, C. Dungo-Arthur, J.A. Carrero, J.M. White, P.J. Hertzog, and R.D. Schreiber Blocking monoclonal antibodies specific for mouse IFN-alpha/beta receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection J. Interferon Cytokine Res. 26 2006 804 819
39. J.M. Shulman, and P.L. De Jager Evidence for a common pathway linking neurodegenerative diseases Nat. Genet. 41 2009 1261 1262
40. M.G. Tansey, T.C. Frank-Cannon, M.K. McCoy, J.K. Lee, T.N. Martinez, F.E. McAlpine, K.A. Ruhn, and T.A. Tran Neuroinflammation in Parkinson's disease: is there sufficient evidence for mechanism-based interventional therapy? Front. Biosci. 13 2008 709 717
41. I. Teige, A. Treschow, A. Teige, R. Mattsson, V. Navikas, T. Leanderson, R. Holmdahl, and S. Issazadeh-Navikas IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis J. Immunol. 170 2003 4776 4784
42. I. Teige, Y. Liu, and S. Issazadeh-Navikas IFN-beta inhibits T cell activation capacity of central nervous system APCs J. Immunol. 177 2006 3542 3553
43. M.A. Thenganatt, and J. Jankovic Parkinson disease subtypes JAMA Neurol. 71 2014 499 504
44. C.V. Vorhees, and M.T. Williams Morris water maze: procedures for assessing spatial and related forms of learning and memory Nat. Protoc. 1 2006 848 858
45. W. Wang, I. Perovic, J. Chittuluru, A. Kaganovich, L.T. Nguyen, J. Liao, J.R. Auclair, D. Johnson, A. Landeru, A.K. Simorellis, and et al. A soluble α-synuclein construct forms a dynamic tetramer Proc. Natl. Acad. Sci. USA 108 2011 17797 17802
46. V.W. Yong, S. Chabot, O. Stuve, and G. Williams Interferon beta in the treatment of multiple sclerosis: mechanisms of action Neurology 51 1998 682 689